Abuzar Abdalla
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Abuzar Abdalla has a total of 41 co-authors. Here are the top co-authors by number of shared publications:
- Mohammed Eltahir Abdelhag
Department of Computer Science, College of Engineering and Computer Science, Jazan University, Jazan 82722, Saudi Arabia
2 shared publications - Abdelgabar Omer Yousife Abdelaati
Department of Internal Medicine, King Abdullah Hospital, Bisha, Saudi Arabia
1 shared publication - Abdullah Ali Alqarni
Department of Internal Medicine, College of Medicine, University of Bisha, Bisha, Saudi Arabia
1 shared publication - Ahmed Kadry Araquib
Cardiology Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt
1 shared publication - Alfadil Ahmed Hamdan
Jazan University
1 shared publication - Amal Mohamed Khair
Department of Internal Medicine, Faculty of Medicine, Jazan University, 45142 Jazan, Saudi Arabia
1 shared publication
Latest Publications
- 4 October 2026
- Published by Elsevier in Current Problems in Cardiology
- Vol. 52 (1)
A bibliometric review of bibliometric studies published in cardiology journals
- 4 October 2026
- Published by Elsevier in Current Problems in Cardiology
- Vol. 52 (1)
A bibliometric review of bibliometric studies published in cardiology journals
- Open Access
- 29 September 2026
- Published by Springer Nature in Artery Research
- Vol. 32 (1) , 41
Sex-Specific Differences in Coronary Artery Dimensions and Tapering: A Sudanese Angiographic Study
Introduction: Sex-specific anatomical variations in coronary arteries influence procedural outcomes, yet data from the African population remain scarce. Existing benchmarks are largely derived from Western and male-dominant populations. This study aims to provide a comparative morphometric analysis of the LAD and LCX in a Sudanese cohort, highlighting sex-specific differences in tapering, diameters, and lengths. Method: This multicentre retrospective study analyzes 357 coronary angiograms (147 males, 210 females) from three Sudanese cardiac centers (2018–2019) in patients with non-obstructive coronary artery disease (stenosis < 50%). Diameters of the left anterior descending (LAD) and left circumflex (LCX) arteries were measured at origin, mid, and terminal segments, along with total length including the left main coronary artery (LMCA). Measurements were normalized to body surface area (BSA). Tapering was expressed as a percentage reduction in the proximal-to-distal diameter. Sex differences were assessed using t-tests, ANOVA, and Pearson correlations, with additional analyses adjusted for age and BSA. Results: LMCA diameter (3.8 ± 0.5 mm) did not differ by sex. Females had longer LADs (90.97 ± 25.62 mm vs. males: 76.6 ± 27.3 mm; P = 0.001). Females (50.1 ± 20.1%) have greater overall tapering than males (46.5 ± 18.2%), with a significant difference ( P = 0.0024). Diameter-length correlation for LAD was stronger in females ( r = 0.54 vs. males: r = 0.38; P = 0.001). LAD was longer than LCX (85.1 ± 27.2 mm vs. 67.3 ± 21.6 mm; P < 0.001), with females having wider proximal LAD (2.3 ± 0.64 mm vs. 2.14 ± 0.35 mm; P = 0.03). After adjustment for age and BSA, sex remained independently associated with LAD length and tapering. Overall vessel diameters were numerically smaller than values commonly reported in non-African populations. Conclusion: Within the study cohort, significant sex-specific morphometric differences exist. Females have longer LADs (90.97 ± 25.62 mm vs. 76.6 ± 27.3 mm; P < 0.001), exhibit greater overall tapering (50.1 ± 20.1% vs. 46.5 ± 18.2%; P = 0.0024), and demonstrate a stronger diameter-length correlation ( r = 0.54 vs. 0.38; P = 0.001) than males, with sex remaining an independent predictor of LAD length and tapering after adjustment for age and body surface area. The LAD was longer than the LCX (85.1 ± 27.2 mm vs. 67.3 ± 21.6 mm; P < 0.001). Overall vessel diameters in this Sudanese cohort were numerically smaller than those reported in non-African populations, though a direct statistical comparison was not performed. These findings are descriptive and hypothesis-generating, suggesting that population- and sex-specific anatomical benchmarks warrant further investigation in prospective, outcome-based studies.
- 29 September 2026
- Published by Springer Nature in Artery Research
- Vol. 32 (1) , 41
Open AccessSex-Specific Differences in Coronary Artery Dimensions and Tapering: A Sudanese Angiographic Study
Introduction: Sex-specific anatomical variations in coronary arteries influence procedural outcomes, yet data from the African population remain scarce. Existing benchmarks are largely derived from Western and male-dominant populations. This study aims to provide a comparative morphometric analysis of the LAD and LCX in a Sudanese cohort, highlighting sex-specific differences in tapering, diameters, and lengths. Method: This multicentre retrospective study analyzes 357 coronary angiograms (147 males, 210 females) from three Sudanese cardiac centers (2018–2019) in patients with non-obstructive coronary artery disease (stenosis < 50%). Diameters of the left anterior descending (LAD) and left circumflex (LCX) arteries were measured at origin, mid, and terminal segments, along with total length including the left main coronary artery (LMCA). Measurements were normalized to body surface area (BSA). Tapering was expressed as a percentage reduction in the proximal-to-distal diameter. Sex differences were assessed using t-tests, ANOVA, and Pearson correlations, with additional analyses adjusted for age and BSA. Results: LMCA diameter (3.8 ± 0.5 mm) did not differ by sex. Females had longer LADs (90.97 ± 25.62 mm vs. males: 76.6 ± 27.3 mm; P = 0.001). Females (50.1 ± 20.1%) have greater overall tapering than males (46.5 ± 18.2%), with a significant difference ( P = 0.0024). Diameter-length correlation for LAD was stronger in females ( r = 0.54 vs. males: r = 0.38; P = 0.001). LAD was longer than LCX (85.1 ± 27.2 mm vs. 67.3 ± 21.6 mm; P < 0.001), with females having wider proximal LAD (2.3 ± 0.64 mm vs. 2.14 ± 0.35 mm; P = 0.03). After adjustment for age and BSA, sex remained independently associated with LAD length and tapering. Overall vessel diameters were numerically smaller than values commonly reported in non-African populations. Conclusion: Within the study cohort, significant sex-specific morphometric differences exist. Females have longer LADs (90.97 ± 25.62 mm vs. 76.6 ± 27.3 mm; P < 0.001), exhibit greater overall tapering (50.1 ± 20.1% vs. 46.5 ± 18.2%; P = 0.0024), and demonstrate a stronger diameter-length correlation ( r = 0.54 vs. 0.38; P = 0.001) than males, with sex remaining an independent predictor of LAD length and tapering after adjustment for age and body surface area. The LAD was longer than the LCX (85.1 ± 27.2 mm vs. 67.3 ± 21.6 mm; P < 0.001). Overall vessel diameters in this Sudanese cohort were numerically smaller than those reported in non-African populations, though a direct statistical comparison was not performed. These findings are descriptive and hypothesis-generating, suggesting that population- and sex-specific anatomical benchmarks warrant further investigation in prospective, outcome-based studies.
- Open Access
- 29 November 2025
- Published by MDPI AG in Future Internet
- Vol. 17 (12) , 550
The AI-Powered Healthcare Ecosystem: Bridging the Chasm Between Technical Validation and Systemic Integration—A Systematic Review
Artificial intelligence (AI) is increasingly positioned as a transformative force in healthcare. The translation of AI from technical validation to real-world clinical impact remains a critical challenge. This systematic review aims to synthesize the evidence on the AI translational pathway in healthcare, focusing on the systemic barriers and facilitators to integration. Following PRISMA 2020 guidelines, we searched PubMed, Scopus, Web of Science, and IEEE Xplore for studies published between 2000 and 2025. We included peer-reviewed original research, clinical trials, observational studies, and reviews reporting on AI technical validation, clinical deployment, implementation outcomes, or ethical governance. While AI models consistently demonstrate high diagnostic accuracy (92–98% in radiology) and robust predictive performance (AUC 0.76–0.82 in readmission forecasting), clinical adoption remains limited, with only 15–25% of departments integrating AI tools and approximately 60% of projects failing beyond pilot testing. Key barriers include interoperability limitations affecting over half of implementations, lack of clinician trust in unsupervised systems (35%), and regulatory immaturity, with only 27% of countries establishing AI governance frameworks. Moreover, performance disparities exceeding 10% were identified in 28% of models, alongside a pronounced global divide, as 73% of low-resource health systems lack enabling infrastructure. These findings underscore the need for systemic, trustworthy, and equity-driven AI integration strategies.
- 29 November 2025
- Published by MDPI AG in Future Internet
- Vol. 17 (12) , 550
Open AccessThe AI-Powered Healthcare Ecosystem: Bridging the Chasm Between Technical Validation and Systemic Integration—A Systematic Review
Artificial intelligence (AI) is increasingly positioned as a transformative force in healthcare. The translation of AI from technical validation to real-world clinical impact remains a critical challenge. This systematic review aims to synthesize the evidence on the AI translational pathway in healthcare, focusing on the systemic barriers and facilitators to integration. Following PRISMA 2020 guidelines, we searched PubMed, Scopus, Web of Science, and IEEE Xplore for studies published between 2000 and 2025. We included peer-reviewed original research, clinical trials, observational studies, and reviews reporting on AI technical validation, clinical deployment, implementation outcomes, or ethical governance. While AI models consistently demonstrate high diagnostic accuracy (92–98% in radiology) and robust predictive performance (AUC 0.76–0.82 in readmission forecasting), clinical adoption remains limited, with only 15–25% of departments integrating AI tools and approximately 60% of projects failing beyond pilot testing. Key barriers include interoperability limitations affecting over half of implementations, lack of clinician trust in unsupervised systems (35%), and regulatory immaturity, with only 27% of countries establishing AI governance frameworks. Moreover, performance disparities exceeding 10% were identified in 28% of models, alongside a pronounced global divide, as 73% of low-resource health systems lack enabling infrastructure. These findings underscore the need for systemic, trustworthy, and equity-driven AI integration strategies.
- 28 November 2025
- Published by Elsevier in Indian Journal of Tuberculosis
- Vol. 72, S55-S60
AI-powered risk prediction of tuberculosis reactivation in latently infected individuals
- 28 November 2025
- Published by Elsevier in Indian Journal of Tuberculosis
- Vol. 72, S55-S60
AI-powered risk prediction of tuberculosis reactivation in latently infected individuals